A rapid, reliable, sensitive UV-spectrophotometric method has been developed for the determination of Balofloxacin in bulk and marketed tablet dosage form using 1 % w/v of ferrous sulphate as a chromagenic / complexing agent. The yellow colour complex formed by complexation of iron (II) with balofloxacinwas stable and was measured for absorbance at its λ max of 357 nm. The Beers law was obeyed at the concentration range of 10-100 µg / ml with good correlation coefficient of 0.9992. The method was optimized and validated for linearity, accuracy and precision. The proposed method is simple and can be routinely used for the estimation of balofloxacin in its tablet formulations.
INTRODUCTION
Balofloxacin(BLFX),1-cyclopropyl-6-fluoro-8methoxy-7-(3-methylaminopiperidin-1-yl)-4-oxoquinoline-3-carboxylic acid 1 , is a broad spectrum fourth generation fluoroquinolone antibacterial, having a formula as C 20 H 24 FN 3 O 4 and molecular mass 389.42 g / mol. It exhibits excellent antibacterial activity against gram-positive bacteria such as multiple-drug-resistant staphylococci and pneumococci. It acts by binding to and inhibiting topoisomerase II (DNAgyrase) and topoisomerase IV enzymes, which are responsible for the coiling and uncoiling of DNA, which is needed for bacterial cell repair and replication 2 . Several analytical methods such as UV spectrophotometric method 1, 3 , HPLC determination in biological fluids 4 , HPLC determination in human plasma with solid extraction 5 , RP-HPLC 6 , RP-HPLC with fluorescence detection 7 , HPLCElectropray ionization mass spectroscopy 8 , have been developed for determination of Balofloxacin. In the current study a simple, rapid and reliable visible spectrophotometric method was developed and validated for linearity, accuracy, precision and specificity. The method was extended for determination of balofloxacin in the marketed tablet formulation (Baloforce TM Tablet manufactured by Mankind, New Delhi, India).
Balofloxacin

Method
Perkin Elmer Lambda 25 uv / vis spectrophotometer was used for recording the absorbance. Reference standard of Balofloxacin was kindly received from Cirex Pharmaceuticals (P) Ltd, Hyderabad, India. All the solvents used were of analytical grade.
Preparation of standard drug solution
A 1 mg / ml of stock solution was prepared in a 10 ml volumetric flask by dissolving 10 mg of balofloxacin in 0.1N hydrochloric acid, diluting to the mark with the same acid.
Preparation of 1 % w/v of ferrous sulphate (Reagent)
A 1 % w/v of ferrous sulphate reagent was prepared by weighing 100 mg of the solid ferrous sulphate and acidifying in 1 ml of 0.1N hydrochloric acid in 10 ml volumetric flask and diluting up to the mark with water.
Standard Calibration Plot
Aliquots of the stock solution ranging from 0.1 ml to 1 ml were taken in separate 10 ml volumetric flasks and 3.5 ml each of reagent was added, further diluted to the mark with water to get the working standard solution of concentrations 10 -100 μg / ml. The absorbance of each solutions was measured at 357 nm against reagent blank (Figure 1) . A standard calibration curve was prepared by plotting absorbance versus concentration of balofloxacin (Figure 2 ). Further, with optimized conditions, the proposed method was validated for linearity, accuracy, precision, sensitivity, reproducibility and stability of colour. Recovery studies were carried out by mixing standard solutions of the drug at 3 different levels (75 %, 100 % and 125 %) with previously analyzed tablet samples of balofloxacin. The results of the validation study and recovery study is presented in Table 1 and Table 2 respectively.
Estimation of Balofloxacin from tablets
10 tablets of (Baloforce) containing 100 mg of the active ingredient in each tablet was weighed and powdered. Tablet powder, equivalent to 25 mg of balofloxacin was transferred to 25 ml of volumetric flask and sonicated using 5 ml of 0.1N hydrochloric acid at ambient temperature for 15 minutes. The resulting solution was filtered using whatman filter paper no. 42 and volume of solution diluted up to the mark with 0.1N hydrochloric acid. Different aliquot volumes of this solution was taken in 10 ml volumetric flasks to which 3.5 ml of 1 % w/v of ferrous sulphate was added and diluted to mark with water. The absorbance of the sample solutions was recorded against reagent blank prepared in a similar manner, but excluding the sample. The amount of balofloxacin was calculated from the calibration curve (Figure 2 ). 
RESULTS AND DISCUSSION
Balofloxacin, forms a yellow coloured solution after complexing with the iron (II) in 1 % w/v ferrous sulphate. The developed method was linear over the concentration range of 10 -100 μg / ml. Accuracy was determined from recovery study at 3 different levels of 75 %, 100 % and 125 %, by adding standard solution of balofloxacin to previously analysed tablet samples of balofloxacin. Average recovery of 99.02 % to 101.65 % indicated accuracy of the method. Sandell's sensitivity was determined and found to be 3.512 X 10 -2 µg / cm 2 . The colour was found to be stable. The results of assay showed that the amount of drug determined by new method was in good agreement with the label claim of formulation. From the above results it can be concluded that the developed visible spectrophotometric method is simple, rapid, accurate, precise and economical. Hence the method can be applied for quantitative analysis of balofloxacin in bulk and pharmaceutical formulation like tablet dosage form.
